ATE429227T1 - Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats - Google Patents

Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats

Info

Publication number
ATE429227T1
ATE429227T1 AT04805418T AT04805418T ATE429227T1 AT E429227 T1 ATE429227 T1 AT E429227T1 AT 04805418 T AT04805418 T AT 04805418T AT 04805418 T AT04805418 T AT 04805418T AT E429227 T1 ATE429227 T1 AT E429227T1
Authority
AT
Austria
Prior art keywords
pyrazole
pharmaceutical composition
oral administration
acid derivative
carbonic acid
Prior art date
Application number
AT04805418T
Other languages
English (en)
Inventor
Thierry Breul
Jean Claude Gautier
Olivier Saslawski
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE429227T1 publication Critical patent/ATE429227T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04805418T 2003-11-10 2004-11-09 Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats ATE429227T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313259A FR2861992B1 (fr) 2003-11-10 2003-11-10 Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
PCT/FR2004/002875 WO2005046690A1 (fr) 2003-11-10 2004-11-09 Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3­carboxamide

Publications (1)

Publication Number Publication Date
ATE429227T1 true ATE429227T1 (de) 2009-05-15

Family

ID=34508418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805418T ATE429227T1 (de) 2003-11-10 2004-11-09 Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats

Country Status (27)

Country Link
US (2) US20060264469A1 (de)
EP (1) EP1691808B1 (de)
JP (1) JP4767171B2 (de)
KR (1) KR20060108668A (de)
CN (1) CN100528158C (de)
AR (1) AR047237A1 (de)
AT (1) ATE429227T1 (de)
AU (1) AU2004289086A1 (de)
BR (1) BRPI0416341A (de)
CA (1) CA2544413A1 (de)
CY (1) CY1110478T1 (de)
DE (1) DE602004020797D1 (de)
DK (1) DK1691808T3 (de)
ES (1) ES2325373T3 (de)
FR (1) FR2861992B1 (de)
HR (1) HRP20090393T1 (de)
IL (1) IL175556A (de)
MA (1) MA28419B1 (de)
NO (1) NO20062609L (de)
NZ (1) NZ547763A (de)
PL (1) PL1691808T3 (de)
PT (1) PT1691808E (de)
RU (1) RU2321404C1 (de)
SI (1) SI1691808T1 (de)
TW (1) TWI280129B (de)
WO (1) WO2005046690A1 (de)
ZA (1) ZA200604451B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1880715A1 (de) * 2006-07-19 2008-01-23 Abbott GmbH & Co. KG Pharmazeutisch annehmbare lösungsvermittelnde Zusammensetzung und diese enthaltende pharmazeutische Darreichungsform
EP1920767A1 (de) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Schmelzverarbeitete Darreichungsform mit Imatinib
KR101493546B1 (ko) * 2007-08-21 2015-02-16 바실리어 파마슈티카 아게 항균 조성물
MY158809A (en) * 2010-09-22 2016-11-15 Craun Res Sdn Bhd Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
US20130317117A1 (en) * 2010-11-24 2013-11-28 Pharmaceutics International, Inc. Self micro-emulsifying drug delivery system with increased bioavailability

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059691A (en) * 1990-01-22 1991-10-22 American Cyanamid Company N-((dialkylamino)methylene)-substituted pyrazolo (1,5-A)-pyrimidine-3-carboxamides and N-((dialkylamino)methylene)-substituted-4,5-dihydropyrazolo-(1,5-A)-pyrimidine-3-carboxamides
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP1033128B2 (de) * 1993-09-28 2011-11-23 R.P. Scherer GmbH Herstellung von Weichgelatinekapseln
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JPH11504028A (ja) * 1995-04-24 1999-04-06 イースム リサーチ ディベロップメント カンパニー オブ ザ ヒーブル ユニバーシティ オブ エルサレム 油／水エマルジョンを作り出す自己乳化性配合物
WO1996036316A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
KR100382964B1 (ko) * 1997-03-14 2003-05-09 오쓰까 세이야꾸 가부시키가이샤 신규 피리미딘 유도체
FR2761266B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6617426B1 (en) * 1999-06-22 2003-09-09 Merck & Co Inc Cysteinyl protease inhibitors
JP2001151669A (ja) * 1999-11-24 2001-06-05 Nippon Kayaku Co Ltd 経口用自己乳化製剤
IL149186A0 (en) * 1999-12-23 2002-11-10 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
FR2831883B1 (fr) * 2001-11-08 2004-07-23 Sanofi Synthelabo Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
DE60313299T2 (de) * 2002-03-01 2008-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Selbstemulgierende systeme zur abgabe von taxoiden
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process

Also Published As

Publication number Publication date
BRPI0416341A (pt) 2007-02-27
DK1691808T3 (da) 2009-08-03
JP4767171B2 (ja) 2011-09-07
ES2325373T3 (es) 2009-09-02
CA2544413A1 (fr) 2005-05-26
PL1691808T3 (pl) 2009-09-30
TWI280129B (en) 2007-05-01
NO20062609L (no) 2006-06-06
IL175556A0 (en) 2008-04-13
JP2007516960A (ja) 2007-06-28
EP1691808B1 (de) 2009-04-22
RU2321404C1 (ru) 2008-04-10
US20090004261A1 (en) 2009-01-01
WO2005046690A1 (fr) 2005-05-26
NZ547763A (en) 2009-08-28
PT1691808E (pt) 2009-07-14
TW200524597A (en) 2005-08-01
MA28419B1 (fr) 2007-02-01
RU2006120447A (ru) 2007-12-20
EP1691808A1 (de) 2006-08-23
FR2861992A1 (fr) 2005-05-13
SI1691808T1 (sl) 2009-10-31
AU2004289086A1 (en) 2005-05-26
KR20060108668A (ko) 2006-10-18
CN1925856A (zh) 2007-03-07
FR2861992B1 (fr) 2007-07-20
CY1110478T1 (el) 2015-04-29
US20060264469A1 (en) 2006-11-23
ZA200604451B (en) 2007-10-31
CN100528158C (zh) 2009-08-19
HK1102021A1 (en) 2007-11-02
DE602004020797D1 (de) 2009-06-04
AR047237A1 (es) 2006-01-11
IL175556A (en) 2010-11-30
HRP20090393T1 (en) 2009-08-31

Similar Documents

Publication Publication Date Title
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
EP2144609A4 (de) Pharmazeutische formulierungen mit liponsäurederivaten
NL1025069A1 (nl) Aanvaardbaar niet-hygroscopisch tussenproduct van een preparaat dat een hygroscopisch geneesmiddel bevat.
ATE362771T1 (de) Pharmazeutische iressa zusammensetzung enthaltend ein wasserlösliches cellulosederivat
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
EP2068885A4 (de) Vitamin-d-zusammensetzungen und verfahren zur verabreichung an einen menschen
EP2098237A4 (de) Analgetisches mittel mit einem cyclischen phosphatidinsäurederivat
ATE348599T1 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE429227T1 (de) Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats
EP1941896A4 (de) Dipeptid-haltige zusammensetzung zur oralen verabreichung
IL173847A0 (en) Pharmaceutical composition in a form of anhydrous self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE455540T1 (de) Orale dosierform für die kontrollierte arzneimittelfreisetzung
EP1581196A4 (de) Säurelabile arzneimittelzusammensetzungen
FR2842526B1 (fr) Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
ATE370927T1 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ITMI20061741A1 (it) Composizioni farmaceutiche per la somministrazione orale di sostanze proteiche
ITMI20041108A1 (it) Preparato farmaceutico per us topico come spray orale che aiuta a smettere di fumare
UA10359S (uk) Пакування таблеток фармацевтичних «аскорбінова кислота»

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1691808

Country of ref document: EP